The role of insurance providers in supporting treatment and management of hepatitis C patients

• Egile Nagusiak: Masoud Behzadifar (Egilea), Hasan Abolghasem Gorji (Egilea), Aziz Rezapour (Egilea), Meysam Behzadifar (Egilea), Nicola Luigi Bragazzi (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Today, one of the most important global public health challenges is represented by hepatitis C virus (HCV), which imposes relevant costs. Globally speaking, the median cost of HCV-related complications ranges from $280 for an uncomplicated hepatitis to $139,070 for a liver transplantation....